RIP3 A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator

The present invention relates to an anti-cancer adjuvant pharmaceutical composition and an anti-cancer pharmaceutical composition for enhancing reactivity to anti-cancer drugs, which contain a receptor-interacting protein kinase-3 (RIP3) expression accelerator or activator as an active component. In...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, SANG HO, YOO, I SEUL, KIM, YOU SUN, NA, KYU HEUM, YOUM, JI HYUN, SEONG, SEUNG KYOO, WOO, JI YOUNG
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to an anti-cancer adjuvant pharmaceutical composition and an anti-cancer pharmaceutical composition for enhancing reactivity to anti-cancer drugs, which contain a receptor-interacting protein kinase-3 (RIP3) expression accelerator or activator as an active component. In a combination therapy of co-administrating the RIP3 expression accelerator or activator with anti-cancer drugs, the present invention provides a novel use of the anti-cancer adjuvant pharmaceutical composition in which cancer cells can exhibit improved reactivity to the anti-cancer drugs. 본 발명은 RIP3 (Receptor-interacting protein kinase-3) 발현 촉진제 또는 활성화제를 유효성분으로 포함하는 항암제에 대한 반응성을 증진시키는 항암 보조용 약학 조성물 및 항암용 약학 조성물에 관한 것으로, RIP3 발현 촉진제 또는 활성화제와 항암제를 병용투여하는 병용 요법에 있어, 암세포가 항암제에 대해 개선된 반응성을 나타낼 수 있는 항암 보조용 약학 조성물의 신규 용법을 제공한다.